Does TILDRAKIZUMAB Cause Urinary tract infection? 36 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Urinary tract infection have been filed in association with TILDRAKIZUMAB (ILUMYA). This represents 4.1% of all adverse event reports for TILDRAKIZUMAB.
36
Reports of Urinary tract infection with TILDRAKIZUMAB
4.1%
of all TILDRAKIZUMAB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Urinary tract infection From TILDRAKIZUMAB?
Of the 36 reports, 1 (2.8%) resulted in death, 11 (30.6%) required hospitalization, and 1 (2.8%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TILDRAKIZUMAB. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does TILDRAKIZUMAB Cause?
Product dose omission issue (53)
Death (50)
Drug ineffective (50)
Psoriasis (37)
Pneumonia (33)
Off label use (27)
Condition aggravated (25)
Covid-19 (25)
Inappropriate schedule of product administration (22)
Cerebrovascular accident (20)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which TILDRAKIZUMAB Alternatives Have Lower Urinary tract infection Risk?
TILDRAKIZUMAB vs TILDRAKIZUMAB-ASMN
TILDRAKIZUMAB vs TILIDINE
TILDRAKIZUMAB vs TIMOLOL
TILDRAKIZUMAB vs TIMOLOL\TRAVOPROST
TILDRAKIZUMAB vs TINIDAZOLE